 | Up a level |
Voskuilen, Charlotte S; Oo, Htoo Zarni; Genitsch Gratwohl, Vera; Smit, Laura A; Vidal, Alvaro; Meneses, Manuel; Necchi, Andrea; Colecchia, Maurizio; Xylinas, Evanguelos; Fontugne, Jacqueline; Sibony, Mathilde; Rouprêt, Morgan; Lenfant, Louis; Côté, Jean-François; Buser, Lorenz; Saba, Karim; Furrer, Marc A.; van der Heijden, Michiel S; Daugaard, Mads; Black, Peter C; ... (2019). Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Carcinoma. The American journal of surgical pathology, 43(12), pp. 1600-1610. Lippincott Williams & Wilkins 10.1097/PAS.0000000000001371
Dai, Xiangpeng; Gan, Wenjian; Li, Xiaoning; Wang, Shangqian; Zhang, Wei; Huang, Ling; Liu, Shengwu; Zhong, Qing; Guo, Jianping; Zhang, Jinfang; Chen, Ting; Shimizu, Kouhei; Beca, Francisco; Blattner, Mirjam; Vasudevan, Divya; Buckley, Dennis L; Qi, Jun; Buser, Lorenz; Liu, Pengda; Inuzuka, Hiroyuki; ... (2017). Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Nature medicine, 23(9), pp. 1063-1071. Nature Publishing Group 10.1038/nm.4378
